Position in ACAD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,383,068
-$2,991,478 QoQ
Shares Held
241,827
-22.9% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 84.15335145939638.ToString("F0")%
Shared 0.ToString("F0")%
None 15.846648540603622.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GREAT LAKES ADVISORS, LLC holds $63,780,240 across 22 Biotechnology names. ACAD ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,945 | $9,253,051 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
118,926 | $8,930,152 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,232 | $7,905,650 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
71,043 | $7,487,931 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
241,827 | $5,383,068 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
141,048 | $4,699,719 | |
| 7 | DNLI |
Denali Therapeutics Inc.
|
227,110 | $4,360,512 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
135,498 | $3,753,293 |
All Filings in ACAD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,383,068 | 241,827 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,374,546 | 313,536 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,705,218 | 454,790 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $16,997,914 | 788,035 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $10,176,614 | 612,680 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $9,909,238 | 540,013 | Shares | Sole | 2025-02-10 | |
| 2021-03-31 | $12,452,782 | 482,666 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $24,084,478 | 450,514 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||